The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Open accessPublished version of a preprint
Abstract
Recent population studies provide clues that the use of metformin may be associated with reduced incidence and improved prognosis of certain cancers. This drug is widely used in the treatment of type 2 diabetes, where it is often referred to as an "insulin sensitizer" because it not only lowers blood glucose but also reduces the hyperinsulinemia associated with insulin resistance. As insulin and insulin-like growth factors stimulate proliferation of many normal and transformed cell types, agents that facilitate signaling through these receptors would be expected to enhance proliferation. We show here that metformin acts as a growth inhibitor rather than an insulin sensitizer for epithelial cells. Breast cancer cells can be protected against metformin-induced growth inhibition by small interfering RNA against AMP kinase. This shows that AMP kinase pathway activation by metformin, recently shown to be necessary for metformin inhibition of gluconeogenesis in hepatocytes, is also involved in metformin-induced growth inhibition of epithelial cells. The growth inhibition was associated with decreased mammalian target of rapamycin and S6 kinase activation and a general decrease in mRNA translation. These results provide evidence for a mechanism that may contribute to the antineoplastic effects of metformin suggested by recent population studies and justify further work to explore potential roles for activators of AMP kinase in cancer prevention and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some of these mechanisms may be through inhibition of cell growth [148], IGF-1 signaling [149], inhibition of the mTOR pathway [150], reduction of human epidermal growth factor receptor type 2 (HER-2) expression (a major driver of proliferation in breast cancer) [151], inhibition of angiogenesis and inflammation [152], induction of apoptosis and protein 53 (p53) activation [153], cell cycle arrest”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [150]
In the citing paper
“and interference with glucose(266), protein(267, 268), and lipid(269) metabolism of the neoplastic cells.”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [268]
In the citing paper
“In laboratory studies, metformin has been shown to inhibit cell proliferation, reduce colony formation, and cause partial cell cycle arrest in cancer cell lines (81–83).”
From Diabetes and Cancer (2010) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I. P. M., Avizienyte, E., Roth, S., Loukola, A., Bignell, G. R., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,680
Insulin-like growth factors and neoplasia
Pollak, M., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1387 · Cited by 1,477
Self-citationVery high risk of cancer in familial Peutz–Jeghers syndrome
Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, G. J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,435
The LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N. M., Manning, B. D., Lopez, L. V., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,107
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 978
Cited by
Sorted by citations
Items 601–700 of 1,000
Ge, R., Wang, Z., Wu, S., Zhuo, Y., Otsetov, A., Cai, C., Zhong, W., Wu, C., & Olumi, A. F. (2015) · Oncotarget · doi:10.18632/oncotarget.5023 · Cited by 30
Guarnaccia, L., Navone, S. E., Masseroli, M. M., Balsamo, M., Caroli, M., Valtorta, S., Moresco, R. M., Campanella, R., Garzia, E., Riboni, L., et al. (2021) · Cancers · doi:10.3390/cancers14010112 · Cited by 30
NQO1-induced activation of AMPK contributes to cancer cell death by oxygen-glucose deprivation
Lee, H., Oh, E., Choi, B., Park, M., Lee, J.-K., Lee, J., & Park, H. J. (2015) · Scientific Reports · doi:10.1038/srep07769 · Cited by 28
Metformin Treatment for the Prevention and/or Treatment of Breast/Mammary Tumorigenesis
Grossmann, M. E., Yang, D.-Q., Guo, Z., Potter, D. A., & Cleary, M. P. (2015) · Current Pharmacology Reports · doi:10.1007/s40495-015-0032-z · Cited by 28
Synthetic drugs with anti-ageing effects
Kapoor, V. K., Dureja, J., & Chadha, R. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.006 · Cited by 27
Kwon, M., Roh, J., Song, J., Lee, S.-W., Kim, S., Choi, S., & Nam, S. Y. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0426 · Cited by 27
AMPK Activators as a Drug for Diabetes, Cancer and Cardiovascular Disease
Goodman, M. (2014) · Pharmaceutical Regulatory Affairs Open Access · doi:10.4172/2167-7689.1000118 · Cited by 27
Bhat, M., Yanagiya, A., Graber, T. E., Razumilava, N., Bronk, S. F., Zammit, D., Zhao, Y., Zakaria, C., Metrakos, P. P., Pollak, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10671 · Cited by 27
Self-citationCombined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma
Gerthofer, V., Kreutz, M. P., Renner, K., Jachnik, B., Dettmer, K., Oefner, P. J., Riemenschneider, M. J., Proescholdt, M. A., Vollmann‐Zwerenz, A., Hau, P., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092586 · Cited by 28
Raffaele, M., Pittalà, V., Zingales, V., Barbagallo, I. A., Salerno, L., Volti, G. L., Romeo, G., Carota, G., Sorrenti, V., & Vanella, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102593 · Cited by 27
Buga, A., Harper, D. G., Sapper, T. N., Hyde, P. N., Fell, B., Dickerson, R. M., Stoner, J. T., Kackley, M. L., Crabtree, C. D., Decker, D. D., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296523 · Cited by 26
Lee, Y., Doonan, B. B., WU, J. M., & Hsieh, T. (2016) · Oncology Reports · doi:10.3892/or.2016.4740 · Cited by 26
Fasting boosts sensitivity of human skin melanoma to cisplatin-induced cell death
Antunes, F., Corazzari, M., Pereira, G. J. S., Fimia, G. M., Piacentini, M., & Smaili, S. S. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.149 · Cited by 28
Ishimura, E., Nakagawa, T., Moriwaki, K., Hirano, S., Matsumori, Y., & Asahi, M. (2017) · Cancer Science · doi:10.1111/cas.13412 · Cited by 27
Metformin suppresses the proliferation and invasion through NF-kB and MMPs in MCF-7 cell line
Beşli, N., Yenmiş, G., Tunçdemi̇r, M., Saraç, E. Y., Doğan, S., Solakoğlu, S., & Sultuybek, G. K. (2019) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2019-0197 · Cited by 27
Metformin Inhibit Cervical Cancer Migration by Suppressing the FAK/Akt Signaling Pathway
Hakimee, H., Hutamekalin, P., Tanasawet, S., Chonpathompikunlert, P., Tipmanee, V., & Sukketsiri, W. (2019) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2019.20.12.3539 · Cited by 26
Gennari, A., Foca, F., Zamarchi, R., Rocca, A., Amadori, D., DeCensi, A., Bologna, A., Cavanna, L., Gianni, L., Scaltriti, L., et al. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05596-4 · Cited by 27
Colon epithelial proliferation and carcinogenesis in diet‐induced obesity
Takahashi, H., Hosono, K., Endo, H., & Nakajima, A. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12240 · Cited by 26
Do Diabetes Drugs Modify the Risk of Pancreatic Cancer?
Yang, Y. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.022 · Cited by 26
K-ras gene mutation as a predictor of cancer cell responsiveness to metformin
Ma, Y., Guo, F., Wang, W., Shi, H., Li, D., & Wang, Y. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1596 · Cited by 26
Khanal, P., Kang, B. S., Yun, H. J., Cho, H., Makarieva, T. N., & Choi, H. S. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1553 · Cited by 27
Li, J., Li, B., Xu, W., Chan, K. W., Guan, X., Qin, Y., Lee, N. P. Y., Chan, K. T., Law, S. Y.-K., Tsao, S. W., et al. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1121236 · Cited by 26
Metformin Use and the Risk of Esophageal Cancer in Barrett Esophagus
Agrawal, S., Patel, P., Agrawal, A., Makhijani, N., Markert, R. J., & Deidrich, W. (2014) · Southern Medical Journal · doi:10.14423/smj.0000000000000212 · Cited by 26
miR-27a-mediated antiproliferative effects of metformin on the breast cancer cell line MCF-7
Zhao, W., Zhang, X., Liu, J., Sun, B., Tang, H., & Zhang, H. (2016) · Oncology Reports · doi:10.3892/or.2016.5199 · Cited by 26
Metformin inhibits growth and prolactin secretion of pituitary prolactinoma cells and xenografts
Gao, J., Liu, Y., Han, G., Deng, K., Liu, X., Bao, X., Feng, M., Yao, Y., Lian, W., Xing, B., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13963 · Cited by 26
Shi, Y., Ma, Z., Cheng, Q., Wu, Y., Parris, A. B., Kong, L., & Yang, X. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118877 · Cited by 26
Yap, T. A., Olmos, D., Molife, L. R., & Bono, J. S. D. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.602630 · Cited by 25
Glucagon promotes colon cancer cell growth via regulating AMPK and MAPK pathways
Yagi, T., Kubota, E., Koyama, H., Tanaka, T., Kataoka, H., Imaeda, K., & Joh, T. (2018) · Oncotarget · doi:10.18632/oncotarget.24367 · Cited by 25
Zhang, Z., Du, J., Shi, H., Wang, S., Yan, Y., Xu, Q., Zhou, S., Zhao, Z., Mu, Y., Qian, C., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03283-0 · Cited by 26
Mascaraque, M., Gallego-Rentero, M., Morala, J. N., Portillo-Esnaola, M., Cuezva, J. M., González, S., Gilaberte, Y., & Juarranz, Á. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101496 · Cited by 25
Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment
Banella, C., Catalano, G., Travaglini, S., Pelosi, E., Ottone, T., Zaza, A., Guerrera, G., Angelini, D. F., Niscola, P., Divona, M., et al. (2022) · Cancers · doi:10.3390/cancers14102565 · Cited by 26
Diabetes, physical activity and breast cancer among Hispanic women
Sanderson, M., Peltz, G., Pérez, A., Johnson, M., Vernon, S. W., Fernández, M. E., & Fadden, M. K. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2010.06.001 · Cited by 25
Theriau, C. F., Shpilberg, Y., Riddell, M. C., & Connor, M. K. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00862.2015 · Cited by 25
Thomas, L. W., Esposito, C., Stephen, J. M., Costa, A. S. H., Frezza, C., Blacker, T. S., Szabadkai, G., & Ashcroft, M. A. (2019) · Cancer & Metabolism · doi:10.1186/s40170-019-0200-4 · Cited by 25
Cairns, J., Ly, R. C., Niu, N., Kalari, K. R., Carlson, E. E., & Wang, L. (2020) · NAR Cancer · doi:10.1093/narcan/zcaa039 · Cited by 24
Yoo, S., Hou, J., Yi, W., Li, Y., Chen, W., Meng, L., Si, J., & Hou, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-01118-3 · Cited by 25
Farkhondeh, T., Amirabadizadeh, A., Aramjoo, H., Llorens, S., Roshanravan, B., Saeedi, F., Talebi, M., Shakibaei, M., & Samarghandian, S. (2021) · Current Oncology · doi:10.3390/curroncol28020134 · Cited by 24
Metformin inhibits the development and metastasis of colorectal cancer
Sugiura, K., Okabayashi, K., Seishima, R., Ishida, T., Shigeta, K., Tsuruta, M., Hasegawa, H., & Kitagawa, Y. (2022) · Medical Oncology · doi:10.1007/s12032-022-01722-y · Cited by 24
Spierings, L. E. A. M. M., Lagarde, S. M., van Oijen, M. G. H., Gisbertz, S. S., Wilmink, J. W., Hulshof, M. C. C. M., Meijer, S. L., Anderegg, M. C. J., Henegouwen, M. I. V. B., & van Laarhoven, H. W. M. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4850-3 · Cited by 24
Epithelial cell polarity: what flies can teach us about cancer
Bergstralh, D. T., & Johnston, D. S. (2012) · Essays in Biochemistry · doi:10.1042/bse0530129 · Cited by 24
Effects of metformin on retinoblastoma growth in vitro and in vivo
Brodowska, K., Theodoropoulou, S., zu Hörste, M. M., Paschalis, E. I., Takeuchi, K., SCOTT, G., Ramsey, D. J., Kiernan, E. A., Hoang, M. V., Cichy, J., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2650 · Cited by 24
Gene expression module-based chemical function similarity search
Li, Y., Hao, P., Zheng, S., Tu, K., Fan, H., Zhu, R., Ding, G., Wang, C., Wang, C., Li, X., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn610 · Cited by 24
Keizman, D., Ish‐Shalom, M., Sella, A., Gottfried, M., Maimon, N., Peer, A., Hammers, H. J., Eisenberger, M. A., Sinibaldi, V. J., Neiman, V., et al. (2016) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2016.04.012 · Cited by 24
Park, S. Y., Park, C., Park, S., Hong, S. H., Kim, G., Hong, S. H., & Choi, Y. H. (2016) · BioScience Trends · doi:10.5582/bst.2016.01170 · Cited by 25
Suzuki, Y., Enokido, Y., Yamada, K., Inaba, M., Kuwata, K., Hanada, N., Morishita, T., Mizuno, S., & Wakamatsu, N. (2017) · Oncotarget · doi:10.18632/oncotarget.17566 · Cited by 24
Keshandehghan, A., Nikkhah, S., Tahermansouri, H., Keshel, S. H., & Gardaneh, M. (2019) · Nutrition and Cancer · doi:10.1080/01635581.2019.1655073 · Cited by 24
Stauffer, S., Zeng, Y., Santos, M., Zhou, J., Chen, Y., & Dong, J. (2019) · Journal of Cell Science · doi:10.1242/jcs.236000 · Cited by 25
The Chemosensitizing Role of Metformin in Anti-Cancer Therapy
Tang, Z., Tang, N., Jiang, S., Bai, Y., Guan, C., Zhang, W., Fan, S., Huang, Y., Lin, H., & Ying, Y. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620666200918102642 · Cited by 24
A Bibliometrics Analysis of Metformin Development From 1980 to 2019
Song, Y., Ma, P., Gao, Y., Xiao, P., Xu, L., & Liu, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.645810 · Cited by 25
Xu, J., Yin, Z., Shen, H., Gao, W., Qian, Y., Pei, D., Liu, L., & Shu, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079135 · Cited by 23
Metts, J. L., Trucco, M. M., Weiser, D. A., Thompson, P., Sandler, E. S., Smith, T., Crimella, J., Sansil, S. S., Thapa, R., Fridley, B. L., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.5297 · Cited by 23
Metformin associated with photodynamic therapy – A novel oncological direction
Nenu, I., Popescu, T., Aldea, M. D., Craciun, L., Olteanu, D. E., Tatomir, C. B., Bolfă, P., Ion, R., Mureșan, A., & Filip, G. A. (2014) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2014.04.027 · Cited by 23
Randomized Trials Built on Sand: Examples from COPD, Hormone Therapy, and Cancer
Suissa, S. (2012) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10082 · Cited by 23
Melnik, B. C. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.04.047 · Cited by 23
Adiponectin and metformin additively attenuate IL1β-induced malignant potential of colon cancer
Moon, H., & Mantzoros, C. S. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0240 · Cited by 23
Parris, A. B., Zhao, Q., Howard, E. W., Zhao, M., Ma, Z., & Yang, X. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0498-0 · Cited by 24
Metformin and Breast Cancer Stage at Diagnosis: A Population-Based Study
Lega, I. C., Fung, K., Austin, P. C., & Lipscombe, L. L. (2017) · Current Oncology · doi:10.3747/co.24.3380 · Cited by 23
He, X., Yao, M., Zhu, M., Liang, D.-L., Guo, W., Yang, Y., Zhao, R., Ren, T., Ao, X., Wang, W., et al. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1057-0 · Cited by 23
Metformin attenuates hypoxia‑induced resistance to cisplatin in the HepG2 cell line
Fujita, H., Hirose, K., Sato, M., Fujioka, I., Fujita, T., Aoki, M., & Takai, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.9869 · Cited by 23
Shafaee, A., Islamian, J. P., Zarei, D., Mohammadi, M., Nejati‐Koshki, K., Farajollahi, A., Aghamiri, S. M. R., Yamchi, M. R., Baradaran, B., & Jafarabadi, M. A. (2019) · Europe PMC (PubMed Central) · doi:10.30476/ijms.2019.44522 · Cited by 23
Zhang, Z., Liang, K. X., Fan, Y., Gao, Z., Bindoff, L. A., Costea, D. E., & Li, L. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1598727 · Cited by 24
Saif, M. W., Rajagopal, S., Caplain, J., Grimm, E. A., Serebrennikova, O. B., Das, M., Tsichlis, P. N., & Martell, R. E. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-03967-3 · Cited by 24
Metformin and Colorectal Cancer Risk in Diabetic Patients
Ioannou, G. N., & Boyko, E. J. (2011) · Diabetes Care · doi:10.2337/dc11-1447 · Cited by 23
Metformin induces a senescence-associated gene signature in breast cancer cells
Williams, C. C., Singleton, B. A., Llopis, S. D., & Skripnikova, E. V. (2013) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2013.0044 · Cited by 22
Asadian, S., Alibabrdel, M., Daei, N., Cheraghi, H., Jafari, S. M., Noshadirad, E., Jabarpour, M., Siavashi, V., & Nassiri, S. M. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27985 · Cited by 22
Wang, J.-L., Lan, Y., Tsai, Y.-T., Chen, Y.-C., Staniczek, T., Tsou, Y., Yen, C., & Chen, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.688062 · Cited by 22
Szymczak-Pajor, I., Drzewoski, J., Świderska, E., Strycharz, J., Gabryanczyk, A., Kasznicki, J., Bogdańska, M., & Śliwińska, A. (2023) · Pharmaceuticals · doi:10.3390/ph16010115 · Cited by 23
Clinical benefits of metformin in gynecologic oncology
Imai, A., Ichigo, S., Matsunami, K., TAKAGI, H., & Yasuda, K. (2015) · Oncology Letters · doi:10.3892/ol.2015.3262 · Cited by 22
The Hepatitis C Virus Modulates Insulin Signaling Pathway In Vitro Promoting Insulin Resistance
Campo, J. A. D., García-Valdecasas, M., Rojas, L., Rojas, Á., & Romero‐Gómez, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047904 · Cited by 22
Chagpar, R., Martin, R. C. G., Ahmad, S. A., Kim, H. J., Rupp, C. C., Weber, S., Ebelhar, A. J., Gilbert, J. E., Brinkman, A. S., Winslow, E. R., et al. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1448-3 · Cited by 22
de Queiroz, E. A. I. F., Oliveira, M. A., Lobato, N. D. S., Akamine, E. H., Colquhoun, A., de Carvalho, M. H. C., Zyngier, S. B., & Fortes, Z. B. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.03.005 · Cited by 22
AMPKα2 Regulates Bladder Cancer Growth through SKP2-Mediated Degradation of p27
Kopsiaftis, S., Sullivan, K. L., Garg, I., Taylor, J. A., & Claffey, K. P. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0111 · Cited by 22
Spratt, D. E., Beadle, B. M., Zumsteg, Z. S., Rivera, A., Skinner, H. D., Osborne, J. R., Garden, A. S., & Lee, N. Y. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.11.007 · Cited by 23
Oh, S., Cho, Y., Chang, M., Park, S., & Kwon, H. N. (2021) · Metabolites · doi:10.3390/metabo11080480 · Cited by 20
Li, B., Takeda, T., Tsuiji, K., Kondo, A., Kitamura, M., Wong, T. F., & Yaegashi, N. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.706668 · Cited by 21
Mortality risk with sulphonylureas compared to metformin
Holden, S. E., & Currie, C. J. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12280 · Cited by 22
Taira, A. V., Merrick, G. S., Galbreath, R. W., Morris, M., Butler, W. M., & Adamovich, E. (2014) · Journal of Contemporary Brachytherapy · doi:10.5114/jcb.2014.45757 · Cited by 21
Les nouvelles promesses de la metformine
Foretz, M., & Viollet, B. (2014) · médecine/sciences · doi:10.1051/medsci/20143001018 · Cited by 26
Metformin inhibits early stage diethylnitrosamine-induced hepatocarcinogenesis in rats
Jo, W., Yu, E., Chang, M., PARK, H.-K., Choi, H., Ryu, J.-E., Jang, S., LEE, H.-J., JANG, J., & Son, W. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4513 · Cited by 20
Impact of diabetes mellitus on the survival of pancreatic cancer: a meta-analysis
Wang, J., Shen, H., Zhan, M., Wang, W., & Dong, Y. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s95744 · Cited by 21
Faggi, L., Giustina, A., & Tulipano, G. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.030 · Cited by 21
Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology
Czogalla, B., Kahaly, M., Mayr, D. C., Schmoeckel, E., Niesler, B., Hester, A., Zeder-Göß, C., Kolben, T., Burges, A., Mahner, S., et al. (2019) · Cancer Management and Research · doi:10.2147/cmar.s210004 · Cited by 21
Knockdown of LKB1 Sensitizes Endometrial Cancer Cells via AMPK Activation
Rho, S. B., Byun, H. J., Kim, B.-R., & Lee, C. H. (2021) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2021.131 · Cited by 20
Metformin upregulates E-cadherin and inhibits B16F10 cell motility, invasion and migration
Liang, G., DING, M., Lu, H., CAO, N., Niu, Y.-D., Gao, Y., & Lu, J. (2015) · Oncology Letters · doi:10.3892/ol.2015.3475 · Cited by 19
De, A., Chatterjee, S., & Thaker, N. (2015) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s84648 · Cited by 19
Mitra, S., Stemke‐Hale, K., Mills, G. B., & Claerhout, S. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02183.x · Cited by 20
Therapeutic effects of metformin in breast cancer: involvement of the immune system?
Schott, S., Bierhaus, A., Schütz, F., Beckhove, P., Schneeweiß, A., Sohn, C., & Domschke, C. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1062-y · Cited by 19
Rajh, M., Dolinar, K., Miš, K., Pavlin, M., & Pirkmajer, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154747 · Cited by 22
Downregulation of Rab27A contributes to metformin-induced suppression of breast cancer stem cells
Feng, F., Zhang, J., Fan, X., Yuan, F., Jiang, Y., Lv, R., & Ma, Y. (2017) · Oncology Letters · doi:10.3892/ol.2017.6542 · Cited by 19
Patient‐ and Cell Type‐Specific Heterogeneity of Metformin Response
Asiedu, M. K., Barron, M., Aubry, M. C., & Wigle, D. A. (2017) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12898 · Cited by 19
Diabetes and cancer: Debating the link through Ca2+/cAMP signalling
Bergantin, L. B. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.02.017 · Cited by 20
Zhang, W., Shao, W., Dong, Z., Zhang, S., Liu, C., & Chen, S. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1644-8 · Cited by 19
Gu, C., Cheng, J., Zhang, B., Yang, S., Xie, F., Sun, J., Huang, L., Yu, J., & Li, M. (2017) · Europe PMC (PubMed Central) · Cited by 19
Gong, Y., Wang, C., Jiang, Y., Zhang, S., Feng, S., Fu, Y., & Luo, Y. (2020) · Cells · doi:10.3390/cells9010144 · Cited by 19
Metformin reduces the Walker-256 tumor development in obese-MSG rats via AMPK and FOXO3a
de Queiroz, E. A. I. F., Akamine, E. H., de Carvalho, M. H. C., Sampaio, S. C., & Fortes, Z. B. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.11.028 · Cited by 19
Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2
Biernacka, K. M., Persad, R. A., Bahl, A. K., Gillatt, D. A., Holly, J. M. P., & Perks, C. M. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0095 · Cited by 18
Chung, W.-S., Le, P., Kuo, C. J., Chen, T., Kuo, C., Chiou, M., Chou, W., Yeh, T., & Hsu, J. (2020) · Cancers · doi:10.3390/cancers12082013 · Cited by 18
Metformin Potentiates the Anticancer Effect of Everolimus on Cervical Cancer In Vitro and In Vivo
Chen, Y., Wu, J.-X., Yang, S., Chen, M., Chen, T.-H., & Hsiao, Y.-H. (2021) · Cancers · doi:10.3390/cancers13184612 · Cited by 19
The development and benefits of metformin in various diseases
Dong, Y., Qi, Y., Jiang, H., Tian, M., Zhang, Y., Peng, C. S., Li, W.-C., Zhang, Y., Zhou, Y., Zang, Y., et al. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-0998-6 · Cited by 21
Kemnade, J. O., Florez, M. A., Sabichi, A. L., Zhang, J., Jhaveri, P. M., Chen, G., Chen, A. C., Miller-Chism, C. N., Bulsara, S., Hilsenbeck, S. G., et al. (2023) · Oral Oncology · doi:10.1016/j.oraloncology.2023.106536 · Cited by 18
Metadata
- Authors
- Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M.
- Affiliations
- 1Oncology and Departments of
- McGill University (CA)
- Mount Sinai Hospital (CA)
- Venue
- Cancer Research
- Published
- 2006-11-01
- Volume
- 66
- Issue
- 21
- Pages
- 10269-10273
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2078190084
- Cited by
- 1,048
- References
- 20
- Citations by year
- 2026: 13 · 2025: 11 · 2024: 24 · 2023: 29 · 2022: 28 · 2021: 54 · 2020: 47 · 2019: 62 · 2018: 55 · 2017: 70 · 2016: 70 · 2015: 80 · 2014: 93 · 2013: 86 · 2012: 85
- FWCI
- 12.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@McGill (McGill) (submittedVersion)
- Funders
- Canadian Breast Cancer Research Alliance
- Terry Fox Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- metformin, AMP kinase, breast cancer, cell growth inhibition, antineoplastic effects, mTOR, S6 kinase, mRNA translation, insulin resistance, insulin-like growth factor, epithelial cells, cancer prevention
- MeSH terms
- Adenylate Kinase, Antineoplastic Agents, Breast Neoplasms, Female, Humans, Insulin, Metformin, Protein Biosynthesis, Gene Expression Regulation, Enzymologic, RNA, Small Interfering, Cell Line, Tumor, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
